Cardiovascular mortality in schizophrenia: Defining a critical period for prevention

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 64-68

  Srihari, Vinod H ^a   Phutane, Vivek H ^a   Ozkan, Banu ^a   Chwastiak, Lydia ^b   Ratliff, Joseph C ^a   Woods, Scott W ^a   Tek, Cenk ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiovascular mortality; Cardiovascular risk; Critical period; Early intervention; First episode psychosis; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; FLUPHENAZINE; GLUCOSE; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLANZAPINE; PERPHENAZINE; RISPERIDONE; TRIACYLGLYCEROL; ZIPRASIDONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; UNITED STATES; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84875935853     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.01.014     Document Type: Article

References (28)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Supplement 1):S64-S71.
2. Birchwood M., Todd P., Jackson C. Early intervention in psychosis. The critical period hypothesis. Br. J. Psychiatry Suppl. 1998, 172(33):53-59.
3. Brown S., Kim M., Mitchell C., Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br. J. Psychiatry 2010, 196(2):116-121.
4. Centers for Disease Control, Prevention (CDC) (December 20th 2012). http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.
5. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., Roccella E.J. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42(6):1206-1252.
6. Chwastiak L.A., Tek C. The unchanging mortality gap for people with schizophrenia. Lancet 2009, 374(9690):590-592.
7. De Hert M., et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophr. Res. 2008, 101:295-303.
8. Diagnosis and Classification of Diabetes Mellitus Diabetes Care 2004, 27(90001):5S-10S.
9. Drake R.E., Rosenberg S.D., Mueser K.T. Assessing substance use disorder in persons with severe mental illness. New Dir. Ment. Health Serv. 1996, 70:3-17.
10. Druss B.G., Marcus S.C., Campbell J., Cuffel B., Harnett J., Ingoglia C., Mauer B. Medical services for clients in community mental health centers: results from a national survey. Psychiatr. Serv. 2008, 59(8):917-920.
11. Edwards J., McGorry P.D. Multi-component early intervention - models of good practice. Implementing Early Intervention in Psychosis 2002, 63. Martin Dunitz, London. J. Edwards, P.D. McGorry (Eds.).
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, January 1995 FINAL, (SCID-I/P Version 2.0) 1995, Biometrics Research Department, New York State Psychiatric Institute, New York.
13. Foley D.L., Morley K.I. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch. Gen. Psychiatry 2011, 68(6):609-616.
14. Freudenreich O., McEvoy J.P. Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects. Clin. Schizophr. Relat. Psychoses. 2012, 6(3):115-121.
15. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., Lamberti S., D'Agostino R.B., Stroup T.S., Davis S., Lieberman J.A. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 2005, 80(1):45-53.
16. Goldberg R.W., Kreyenbuhl J.A., Medoff D.R., Dickerson F.B., Wohlheiter K., Fang L.J., Brown C.H., Dixon L.B. Quality of diabetes care among adults with serious mental illness. Psychiatr. Serv. 2007, 58(4):536-543.
17. Grundy S.M., Cleeman J.I., Merz C.N., Brewer H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith S.C., Stone N.J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J. Am. Coll. Cardiol. 2004, 44(3):720-732.
18. Liu K., Daviglus M.L., Loria C.M., Colangelo L.A., Spring B., Moller A.C., Lloyd-Jones D.M. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age/clinical perspective. Circulation 2012, 125(8):996-1004.
19. Lloyd-Jones D.M. Improving the cardiovascular health of the US population. J. Am. Med. Assoc. 2012, 307(12):1314-1316.
20. Phutane V.H., Tek C., Chwastiak L., Ratliff J.C., Ozyuksel B., Woods S.W., Srihari V.H. Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?. Schizophr. Res. 2011, 127(1-3):257-261.
21. Ratliff J.C., Palmese L.B., Reutenauer E.L., Liskov E., Grilo C.M., Tek C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr. Psychiatry 2012, 53:1028-1033.
22. Rothman K.J., Lanes S.F., Society for Epidemiologic Research Meeting Causal Inference 1988, Epidemiology Resources, Chestnut Hill, MA.
23. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64(10):1123-1131.
24. Srihari V.H., Tek C., Chwastiak L.A., Woods S.W., Steiner J.L. Best practices: surveillance and management of diabetes in a CMHC population. Psychiatr. Serv. 2007, 58(9):1151-1153.
25. Srihari V.H., et al. Public-Academic Partnerships: Early Intervention for Psychotic Disorders in a Community Mental Health Center. Psychiatr. Serv. 2009, 60:1426-1428.
26. Strasser T. Reflections on cardiovascular diseases. Interdiscip. Sci. Rev. 1978, 3(3):225.
27. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
28. Yang Q., Cogswell M.E., Flanders W.D., Hong Y., Zhang Z., Loustalot F., Gillespie C., Merritt R., Hu F.B. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. J. Am. Med. Assoc. 2012, 307(12):1273-1283.